Abdallah Flaifel

To all pathology fellows/residents interested in a research post-doc focused on prostate cancer==> we have an open position ⁦⁦@DanaFarber_GU⁩ Please email Pr. Signoretti and Taplin: ssignoretti@partners.org mtaplin@partners.org careers.dana-farber.org/job/postdoctor…

Our thoracic pathology fellow @marcelo_cassini was awarded 2nd prize by the Pulmonary Pathology Society for best posters at USCAP 2023! His “Histolopathologic analysis of donor lung at time of transplant and correlation with outcomes” took their breath away. Congrats, Marcelo!!

What better way to kick off the wellness activities of this academic year than a day trip to @StormKingArtCtr to admire large-scale sculptures under open skies? A fun day filled with art, camaraderie and relaxation #PathTwitter #pathresidents #wellness #path2path #PathMatch2023

Every person’s cancer is different. There’s no guarantee a given treatment is going to work. But a team of researchers hope to soon offer #oncologists a new tool to guide treatment choices for their patients, based on results from a small study cancer.gov/news-events/ca… #OncTwitter

@AminNassarMD @BrighamMedRes @YaleHemOnc Congratulations!

So grateful for everything @BrighamMedRes has given me. Mostly consider myself super lucky to get to know phenomenal lifetime friends and future healthcare leaders!! Excited for @YaleHemOnc!

Mutations in cancer-related genes that start in embryos may be more common than once thought, a new study has shown. Finding out if a person has a mosaic mutation is important for their cancer care, according to the study leaders. cancer.gov/news-events/ca… @MSKCancerCenter

"I'm a bit ashamed to admit this, but I was trying to hide the fact that I came from Lebanon." 2021 medicine laureate Ardem Patapoutian (@ardemp) shares his personal story of inclusion and how proud he is of his background (something that hasn't always been the case).

Reporting live from @TheUSCAP and proudly sharing more of our trainees’ presentations! Featured below: @lswang13 (PGY4), Hasanain Hasan MBChB (PGY3), and our #cytopath fellows Christine Kim MD and Fei Chen MD/PhD. Fun fact: @cf450 is also a graduate from our residency program!

As part of @TheUSCAP activities, the @nyulangone Pathology Alumni Reception is happening now! It’s so good to see so many familiar faces after a two year hiatus, cheers! 🥂 #PathTwitter #path2path #USCAP2022

It's so nice to be back at USCAP! @nyugrossman @NYUGSOMpathres

@anotherpathres Congrats!

Now online in @CD_AACR: Characterization of INCB086550, a potent and novel small-molecule PD-L1 inhibitor @Incyte #immunotherapy aacrjournals.org/cancerdiscover…

Last Sunday some of our residents and SOs went snow tubing to properly send off the winter followed by dinner at the @mountaincreek resort, all payed for by our wellness initiative! Who’s ready for spring? #residentwellness #NYUPath #path2path #PathMatch22

@nyulangone #lungtransplant and pathology teams including @Flaifel_A @FuzzFree @AndreMo77438628 describe the #pulmonary pathology of end-stage #COVID19 disease in explanted lungs and outcomes after transplant in @AJPathology 🔓 bit.ly/35Vm4rl #mededmonday

#OnlineFirst: Prolonged SARS-CoV-2 infection in patients with lymphoid malignancies. bit.ly/30ft2on @christinaleemd @SantoshVardhana @VardhanaLab @sloan_kettering #lymphoma #COVID19

What drives organization of RNA, DNA, and proteins in the nucleus? In our new paper out @CellCellPress, we show that non-coding RNAs play a central role through a unique RNA-based mechanism. authors.elsevier.com/c/1e132L7PXf05J

The #AMPath21 Digital Experience Corporate Workshop Program is now live! Plan your virtual experience for the week of November 15-19 today: ow.ly/qhX350GFuIZ #molpath #pathologists

Excited to share our labs newest preprint where we used CRISPR/Cas9 screening with LSD1 inhibitors to identify genes that cause LSD1 inhibitor resistance and block SCLC neuroendocrine differentiation. 1/ biorxiv.org/content/10.110…...

Dr. Matija Snuderl, director of Molecular Pathology Services treated the entire #molecularpath lab to celebrate the @US_FDA clearance of the NYU Langone Genome PACT (Profiling of Actionable Cancer Targets), the largest tumor NGS testing in the country with 607 exons analyzed 🧬

would rather talk to a rude person who i know is real & genuine than a fake smile hiding indifference.